A major advance in cancer research is emerging with the use of mini-antibodies to restore damaged p53. This essential tumor inhibitor protein is frequently inactivated in various types of malignancies, resulting https://bookmarkwuzz.com/story21959895/nanobodies-reactivate-the-p53-protein-the-promising-pathway-for-cancer-management